Benzinga's Volume Movers

surged 47.69 percent to $13.75. The volume of Elizabeth Arden shares traded was 101384 percent higher than normal.

agreed to acquire Elizabeth Arden for $14.00 per share in cash, for an enterprise value of around $870 million.

shares moved up 7.54 percent to $17.68. The volume of Paratek Pharmaceuticals traded was 2278 percent higher than normal. Paratek reported that Omadacycline has met all primary and secondary efficacy outcomes designated by the FDA and EMA in a Phase 3 study in acute bacterial skin infections.

shares climbed 7.61 percent to $23.40. The volume of Smith & Wesson shares traded was 892 percent higher than normal. Smith & Wesson posted upbeat results for its fourth quarter and issued a strong forecast for the year.

shares rose 6.63 percent to $18.75. The volume of Finisar shares traded was 626 percent higher than normal. Finisar reported better-than-expected earnings for its fourth quarter and issued strong earnings guidance for the current quarter.